Valuation Tonix Pharmaceuticals Nasdaq

Stocks

End-of-day quote Nasdaq 05/02/2024			5-day change	1st Jan Change
0.3222 ^USD	-2.36%		+2.32%	-20.05%

09-22	Tonix Pharmaceuticals Holding Corp. Announces Second Major Managed Medicare Payer Agreement for TONMYA®	CI
09-08	Tonix Pharmaceuticals Holding Corp. Announces Appointment of Thomas Englese to Chief Commercial Officer, Effective September 8, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	177.4	22.42	23.62	61.64	193.6	152.8	-	-
Change	-	-87.36%	5.35%	160.94%	214.02%	-21.05%	-	-
Enterprise Value (EV)	177.4	22.42	23.62	61.64	193.6	152.8	152.8	152.8
Change	-	-87.36%	5.35%	160.94%	214.02%	-21.05%	0%	0%
P/E	-1.38x	-0.12x	-0.06x	-0.19x	-1.07x	-0.91x	-1.35x	-2.62x
PBR	-	-	-	-	-	-	-	-
PEG	-	0x	0x	0x	0x	0x	0x	0.1x
Capitalization / Revenue	-	-	3.04x	6.11x	14.8x	2.78x	1.38x	0.84x
EV / Revenue	-	-	0x	0x	0x	2.78x	1.38x	0.84x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-0.88x	-0.94x	-1.27x
EV / FCF	-	-	-	-	-	-0.78x	-0.75x	-0.96x
FCF Yield	-	-	-	-	-	-128%	-134%	-105%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-166,400	-65,400	-21,920	-176.6	-14.57	-9.792	-6.617	-3.397
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	7.768	10.09	13.11	55	110.9	181.4
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-92.31	-112.1	-118.4	-136.7	-125.7	-173.3	-161.9	-120.7
Net income ¹	-92.29	-116.9	-116.7	-130	-124	-168.7	-164.3	-115.4
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	228,928.000	7,796.000	1,289.600	32.980	15.620	8.910	8.910	8.910
Nbr of stocks (in thousands)	0.78	2.88	18.3	1,869	12,392	17,151	-	-
Announcement Date	14/03/22	13/03/23	01/04/24	18/03/25	12/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.45x	11.78x	23.93x	0.61%	1,019B
JOHNSON & JOHNSON	28.48x	6.32x	17.74x	2.09%	617B
ABBVIE INC.	33.26x	7.78x	16.08x	2.64%	464B
MERCK & CO., INC.	104.98x	5.87x	24.89x	2.36%	356B
ROCHE HOLDING AG	18.81x	4.58x	11.36x	2.9%	333B
NOVARTIS AG	19.83x	5.17x	12.78x	3.09%	267B
ASTRAZENECA PLC	20.02x	4.17x	11.86x	2.13%	244B
AMGEN INC.	25.46x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.78x	6.39x	24.97x	2.27%	179B
Average	26.61x	6.52x	17.28x	2.29%	410.8B
Weighted average by Cap.	31.80x	7.61x	18.61x	1.96%